Kelly Huang, Elucid - Studio Interview | LSI USA '25

Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine.

LSI USA ‘26 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

March 16th - 20th, 2026  Waldorf Astoria, Monarch Beach Register arrow